PZ Wind Down Inc (PZRXQ)
PZ Wind Down Inc. (PZRX.Q) is listed on OTC Markets as common stock and is associated with a healthcare business focused on biotechnology. The underlying company, formerly PhaseRx, Inc., was a biopharmaceutical firm developing treatments for inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy. Its proprietary Hybrid mRNA platform was designed to enable cells to produce missing enzymes internally. The company’s development programs included PRX-OTC for ornithine transcarbamylase deficiency, PRX-ASL for argininosuccinate lyase deficiency, and PRX-ASS1 for argininosuccinate synthetase deficiency. PhaseRx was incorporated in 2006 and is headquartered in Seattle, Washington.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-PZRX.Q
|
—
|
—
|
—
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
0.011 K
|
—
|
—
|
—
|
—
|
—
|
—
|